It is the oldest and most prolific cancer known in nature.
Academic rigour, journalistic flair
Articles on Cancer
Displaying 141 - 160 of 864 articles
Emerging evidence shows the COVID pandemic has seen fewer people receiving routine medical care across many areas. Here’s what we know about the impact that’s having – and could have down the track.
Molecular research is expensive, but worth it because of the burden of disease that it could relieve.
One promising cancer treatment has been in the works for decades, but severe side effects have kept it out of the clinic. A reengineered version may offer a way to safely harness its potent effects.
The immortal cancer cells of Henrietta Lacks revolutionized the fields of science, medicine and bioethics. And they still survive today, more than 70 years after her death.
Belonging to one or more groups with long-standing social and economic disadvantages increases the risk of cancer diagnoses and death.
Tumors contain thousands of genetic changes, but only a few are actually cancer-causing. A quicker way to identify these driver mutations could lead to more targeted cancer treatments.
Globally, most cancer patients die not because they don’t have access to newer drugs, but because they don’t have access to even basic treatments. Cancer groundshot aims to improve treatment access.
Cell cultures have shown promise in representing diseases. The Petri dish is not as different from a sick person as one might think.
There are currently no effective tests to screen for ovarian cancer. But that doesn’t mean there aren’t ways to recognize and prevent it.
Greater focus on preventing cancer including a more personalised screening programme could make a real difference, one expert argues.
The health risks of e-cigarettes outweigh any benefits, a comprehensive review of the evidence shows.
In future health emergencies and possibly further waves of the COVID-19 pandemic, caution needs to be taken when extending cancer waiting times for reasons unrelated to patients’ health-care needs.
Treating companion animals like cats and dogs for cancer can bring us closer to a cure for humans.
A study of over 100,000 people found aspartame and acesulfame K in particular may increase risk of developing cancer somewhat.
Preclinical studies are an important part of biomedical research, often guiding future trials in humans. Failure to replicate research results suggests a need to increase the quality of studies.
We’ve found an unusual way of stabilising the cancer-suppressing protein p53.
Disruptions to the lung microbiome are linked to a number of respiratory conditions in both children and adults.
New research on cat and dog health may provide clues on how to prevent and treat cancer in humans.
Eating less meat was also linked with a lower risk of colorectal, breast, and prostate cancer.
Top contributors
-
Adjunct Professsor, School of Psychology, Faculty of Health and Medical Sciences, University of Adelaide
-
Professor, Macquarie University
-
Professor, School of Medicine, University of Connecticut
-
Adjunct Professor, School of Psychology, Curtin University and College of Health and Medicine, Australian National University
-
Professor, Department of Biomedical and Life Sciences, Lancaster University
-
Laureate Professor in Nutrition and Dietetics, University of Newcastle
-
Associate professor, University of Sydney
-
Graduate Student in Cancer Systems Biology, Rice University
-
Professor of Health Psychology, University of Wollongong
-
Professor of Sociology & Director, Sydney Centre for Healthy Societies, University of Sydney
-
Professor of Oncology, University of Tasmania
-
Senior Visiting Fellow, School of Medical Sciences, UNSW Sydney
-
Associate Professor, Deakin University
-
Professor of Physical Activity, Lifestyle, and Population Health, University of Sydney
-
Emeritus Professor in Public Health, University of Sydney
